US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
LianBio (PK) (LIANY) 銘柄情報

LianBio (PK) (LIANY)

0.1106

0.00

(0.00%)

終了 7月11日 5:00AM

LianBio (PK) (LIANY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.1106

( - )

買値

0.0994

売値

0.1649

出来高

3

平均取引量 (3 か月)

US$ 5,347

財務取引量

-

0.00 日の範囲 0.00

0.03 52 週間の範囲 0.438

時価総額

企業価値

-

前日終値

0.1106

始値

-

時刻

最終取引時間

VWAP

-

歳入

-

純利益

-87.98M

発行済株式数

108,165,130

浮動株比率 (%)

-

機関投資家保有比率 (%)

7.46%

配当利回り

PER

-0.14

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0.82

ベータ

0.07

LianBio, operates as a biotechnology company in China and other Asian countries. It offers medicines for cardiovascular, oncology, ophthalmology, and inflammatory disease indications. The company develops mavacamten for the treatment of obstructive hypertrophic cardiomyopathy, which is in Phase 3 EX... LianBio, operates as a biotechnology company in China and other Asian countries. It offers medicines for cardiovascular, oncology, ophthalmology, and inflammatory disease indications. The company develops mavacamten for the treatment of obstructive hypertrophic cardiomyopathy, which is in Phase 3 EXPLORER-CN trial; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease, which is in Phase 3 LIBRA trial; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of FGFR2 gene amplification; and BBP-398 for solid tumors. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.lianbio.com

本社

Princeton, United States

設立

2026

LianBio (PK) is listed in the sector of the その他OTC with ticker LIANY. The last closing price for LianBio (PK) was US$0.11. Over the last year, LianBio (PK) shares have traded in a share price range of US$ 0.03 to US$ 0.438.

LianBio (PK) currently has 108,165,130 shares in issue. The market capitalisation of LianBio (PK) is US$11.96 million. LianBio (PK) has a price to earnings ratio (PE ratio) of -0.14.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.1106	0.14018	0.1106	10972	0.1106	DR
4	-0.0493	-30.8317698562	0.1599	0.1599	0.1106	2505	0.11461069	DR
12	-0.0116	-9.49263502455	0.1222	0.1649	0.0901	5803	0.11362909	DR
26	0.0176	18.9247311828	0.093	0.1768	0.0901	53012	0.13881511	DR
52	-0.3208	-74.3625405656	0.4314	0.438	0.03	112821	0.13520824	DR
156	-0.1694	-60.5	0.28	0.4394	0.03	100183	0.25262318	DR
260	-0.1694	-60.5	0.28	0.4394	0.03	100183	0.25262318	DR

LIANY - Frequently Asked Questions (FAQ)

What is the current LianBio (PK) share price?

The current share price of LianBio (PK) is US$ 0.1106

How many LianBio (PK) shares are in issue?

LianBio (PK) has 108,165,130 shares in issue

What is the market cap of LianBio (PK)?

The market capitalisation of LianBio (PK) is USD 11.96M

What is the 1 year trading range for LianBio (PK) share price?

LianBio (PK) has traded in the range of US$ 0.03 to US$ 0.438 during the past year

What is the PE ratio of LianBio (PK)?

The price to earnings ratio of LianBio (PK) is -0.14

What is the registered address of LianBio (PK)?

The registered address for LianBio (PK) is 103 Carnegie Center Drive, Princeton, New Jersey, 08540

What is the LianBio (PK) website address?

The website address for LianBio (PK) is www.lianbio.com

shazam1355

shazam1355 4分前

WOW.... back up to 20 million. Does anyone have any thoughts on why this is? Just throwing out some ideas below and see if anyone can share what possibilities they are for why it increased so much ? Any feedback would be appreciated. Kind of sucks to see this happen.

Does this have

Doc logic

Doc logic 5分前

meirluc,

You point to “the process” and “the process” stinks because of the lives it sacrifices in situations PRECISELY like this.
There was enough evidence in 2012 to let terminally ill patients decide for themselves to spend their insurance money on something potentially be

Idunno

Do you think he will be the subject of a Deposition Subpoena, as a witness, if/when we get to a civil trial?

Lonewolf1

Lonewolf1 7分前

MU is a different stock now.
Way off the highs and we've had an up market.

Zardiw

$BURU is moving - DDAmanda Chart

https://DDAmanda.com/

https://DDAmanda.com/Charts/DDAmandaBURU.jpg

#DDAmanda

Z

Zardiw

$BURU is moving - DDAmanda Chart

https://DDAmanda.com/

https://DDAmanda.com/Charts/DDAmandaBURU.jpg

#DDAmanda

Z

Jetmek_03052

Jetmek_03052 9分前

I’ll tell you the “tune” they’re “dancing” to - it’s a tune called the “Shysters Lullaby”.

They’ve not done a SINGLE THING so far in the 2026 Fiscal year to help the company. They are counting on some sort of AI HYPE to convince shareholders that good things are on the way.

vlispxpert

vlispxpert 9分前

GPUS #47 on list with 1k bitcoin, only entered top 100 list in Nov 2025 ..maybe they aren't joking about being in the top 10:

November 24, 2025 6:00 AM
Hyperscale Data Joins the Global Top 100 Public Bitcoin Treasury Companies with Current Holdings of Approximate

rmoss

Or maybe im wrong who knows ill admit it if so im just looking at what chat got and Google and Ai says about it. Check them if you want.

rmoss

Hey they still have 1.5 bil common that they can pull on board anytime they think they need money or a raise. Yes t h e float is low but don't look for it to stay that way long. It is the otc

Zardiw

Zardiw 14分前

What are CSP's ...........Call options?......

Z

Abig

https://investorshub.advfn.com/uimage/uploads/2026/7/10/cvsfp1783723839140.jpg

looks good to me!!!!

SSKILLZ1

SSKILLZ1 16分前

PVIS.V Was the best performing stock pick today picked by VALUEMIND to start the contest. hope this helps

Zardiw

Zardiw 16分前

Found Early: $GMM - Up 147% - DDAmanda Chart

https://DDAmanda.com/

https://DDAmanda.com/Charts/DDAmandaGMM.jpg

#DDAmanda

Z

CryptoRain

CryptoRain 17分前

Nah these guys know what they’re doing, no worries

Zardiw

Zardiw 18分前

Found Early: $GMM - Up 147% - DDAmanda Chart

https://DDAmanda.com/

https://DDAmanda.com/Charts/DDAmandaGMM.jpg

#DDAmanda

Z

NHPIPIXiPY$26

NHPIPIXiPY$26 18分前

I played the 200 day support here but quickly exited when it failed to hold. Post trade analysis: I broke my rule about catching falling knives, I failed to check money flow or downside volume before taking a position and I didn't learn about the July Lanteris insider unlock until after I entered.

JMoneyHoops

JMoneyHoops 18分前

Why is this stuck in quicksand with that much volume!?

learningcurve2020

learningcurve2020 18分前

October!…aka After the summer. LOL. Ignore me but I was the one who brought that CTBVEAG evidence here. Then I had to fight a hostile crowd here so provided plenty of back up evidence that the group chimed in on more than just trials. Then I provided another link that was likely the pediatric trial

vlispxpert

vlispxpert 19分前

Busted theory, well, I'm always looking for those "patterns"...have a great weekend all!

mauiguy2

mauiguy2 20分前

I did indeed. But, why the "us in Germany"? Sure sounds like you're in Germany now.

Anyway, it's not important. Just curious.

srm4u

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175755390
https://www.otcmarkets.com/stock/BKTH/security
https://www.otcmarkets.com/stock/BKTH/news

RRP60

Baxers, thanks for taking time to write your honest opinion on the ongoing matters. I respect what you wrote. We know our processing is not going kosher and clean because we are into third year. If your suspicion turn out to be true, it will be a non issue at this point as we have already come up wi

Dennis14

Dennis14 23分前

https://www.google.com/search?q=context+therapeutics+have+any+treatment+in+phase+2+or+3+clinical+trials&client=safari&hs=VJZV&sca_esv=1ad521229e66d4b0&source=hp&ei=1IJRaumGHZbDp84PkqKruQM&iflsig=ABILxe8AAAAAalGQ5BZ-516lRH-y1OjGfXTYHwYbR4kF&aep=22&udm=50&ved=0ahUKEwjpwLqUpMmVAxWW4ckDHRLRKjcQteYPCBQ&c

Idiot Mayor

Idiot Mayor 23分前

“A sense of what the company is doing”???? 🤣🤣🤣🤣🤣🤣🤣🤣🤣 Ohhhhh I can’t WAIT to hear your expert assessment. Are you going to base it on the profits? The revenue? The decreasing debt?

You haven’t been able to proper

PLASCAR PART ON

FIDC BB Votorantim Highl...

Up Global Sourcing

OMRX Deposit Overnight

Fidelity Canadian Money ...

NetClass Technology

Amtech Sys Inc Dl 01

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。